K

Kyntra Bio Inc
D

KYNB

6.92000
USD
-0.03
(-0.43%)
مغلق
حجم التداول
0
الربح لكل سهم
-15
العائد الربحي
-
P/E
-0
حجم السوق
28,012,935
المقالات
المزيد

العنوان: Kyntra Bio Inc

القطاع: Healthcare
الصناعة: Biotechnology
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.